TY - JOUR
T1 - Computed tomography angiography versus Agatston score for diagnosis of coronary artery disease in patients with stable chest pain
T2 - individual patient data meta-analysis of the international COME-CCT Consortium
AU - on behalf of the COME-CCT Consortium
AU - Wieske, Viktoria
AU - Walther, Mario
AU - Dubourg, Benjamin
AU - Alkadhi, Hatem
AU - Nørgaard, Bjarne L.
AU - Meijs, Matthijs F.L.
AU - Diederichsen, Axel C.P.
AU - Wan, Yung Liang
AU - Mickley, Hans
AU - Nikolaou, Konstantin
AU - Shabestari, Abbas A.
AU - Halvorsen, Bjørn A.
AU - Martuscelli, Eugenio
AU - Sun, Kai
AU - Herzog, Bernhard A.
AU - Marcus, Roy P.
AU - Leschka, Sebastian
AU - Garcia, Mario J.
AU - Ovrehus, Kristian A.
AU - Knuuti, Juhani
AU - Mendoza-Rodriguez, Vladymir
AU - Bettencourt, Nuno
AU - Muraglia, Simone
AU - Buechel, Ronny R.
AU - Kaufmann, Philipp A.
AU - Zimmermann, Elke
AU - Tardif, Jean Claude
AU - Budoff, Matthew J.
AU - Schlattmann, Peter
AU - Dewey, Marc
N1 - Funding Information:
VW reports grant support from the FP7 Program of the European Commission for the randomized multicentre DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2). BLN reports grants from Siemens and HeartFlow. KN reports collaborations with and project funding from Siemens Healthineers, Bayer Healthcare, and GE Healthcare, and participation in Siemens Healthineers speakers bureau, Bayer Healthcare. RRB reports that the University Hospital Zurich holds a research agreement with GE Healthcare. PAK reports that the University Hospital Zurich holds a research agreement with GE Healthcare. PS and MD report support from the joint programme of the German Research Foundation and the German Federal Ministry of Education and Research for the submitted work. MJB reports grant support from General Electric and NIH. PS reports support from the German Research Foundation and grants from the European Union and grants from Bayer Pharma AG. MD has received grant support from the FP7 Program of the European Commission for the randomized multicentre DISCHARGE trial (603266-2, HEALTH-2012.2.4.-2). He also received grant support from German Research Foundation (DFG) in the Heisenberg Program (DE 1361/14-1), graduate program on quantitative biomedical imaging (BIOQIC, GRK 2260/1), for fractal analysis of myocardial perfusion (DE 1361/18-1), the Priority Programme Radiomics for the investigation of coronary plaque and coronary flow (DE 1361/19-1 [428222922] and 20-1 [428223139] in SPP 2177/1). He also received funding from the Berlin University Alliance (GC_SC_PC 27) and from the Digital Health Accelerator of the Berlin Institute of Health. Prof. Dewey has received lecture fees from Canon and Guerbet. Prof. Dewey is European Society of Radiology (ESR) Research Chair (2019–2022) and the opinions expressed in this article are the author’s own and do not represent the view of ESR. Per the guiding principles of ESR, the work as Research Chair is on a voluntary basis and only remuneration of travel expenses occurs. Prof. Dewey is also the editor of Cardiac CT, published by Springer Nature, and offers hands-on courses on CT imaging ( www.ct-kurs.de ). Institutional master research agreements exist with Siemens, General Electric, Philips, and Canon. The terms of these arrangements are managed by the legal department of Charité – Universitätsmedizin Berlin. Professor Dewey holds a joint patent with Florian Michallek on dynamic perfusion analysis using fractal analysis (PCT/EP2016/071551). MW, BD, HA, MFLM, AD, YLW, HM, AAS, BAH, EM, KS, BH, RM, SL, MG, KAO, JK, VMR, NB, SM, EZ, and JCT have nothing to disclose.
Funding Information:
Open Access funding enabled and organized by Projekt DEAL. This work was supported by the joint programme of the German Research Foundation (DFG) and the German Federal Ministry of Education and Research (BMBF, 01KG1110) to Peter Schlattmann and Marc Dewey.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/8
Y1 - 2022/8
N2 - Objectives: There is conflicting evidence about the comparative diagnostic accuracy of the Agatston score versus computed tomography angiography (CTA) in patients with suspected obstructive coronary artery disease (CAD). Purpose: To determine whether CTA is superior to the Agatston score in the diagnosis of CAD. Methods: In total 2452 patients with stable chest pain and a clinical indication for invasive coronary angiography (ICA) for suspected CAD were included by the Collaborative Meta-analysis of Cardiac CT (COME-CCT) Consortium. An Agatston score of > 400 was considered positive, and obstructive CAD defined as at least 50% coronary diameter stenosis on ICA was used as the reference standard. Results: Obstructive CAD was diagnosed in 44.9% of patients (1100/2452). The median Agatston score was 74. Diagnostic accuracy of CTA for the detection of obstructive CAD (81.1%, 95% confidence interval [CI]: 77.5 to 84.1%) was significantly higher than that of the Agatston score (68.8%, 95% CI: 64.2 to 73.1%, p < 0.001). Among patients with an Agatston score of zero, 17% (101/600) had obstructive CAD. Diagnostic accuracy of CTA was not significantly different in patients with low to intermediate (1 to < 100, 100–400) versus moderate to high Agatston scores (401–1000, > 1000). Conclusions: Results in our international cohort show CTA to have significantly higher diagnostic accuracy than the Agatston score in patients with stable chest pain, suspected CAD, and a clinical indication for ICA. Diagnostic performance of CTA is not affected by a higher Agatston score while an Agatston score of zero does not reliably exclude obstructive CAD. Key Points: • CTA showed significantly higher diagnostic accuracy (81.1%, 95% confidence interval [CI]: 77.5 to 84.1%) for diagnosis of coronary artery disease when compared to the Agatston score (68.8%, 95% CI: 64.2 to 73.1%, p < 0.001). • Diagnostic performance of CTA was not affected by increased amount of calcium and was not significantly different in patients with low to intermediate (1 to <100, 100–400) versus moderate to high Agatston scores (401–1000, > 1000). • Seventeen percent of patients with an Agatston score of zero showed obstructive coronary artery disease by invasive angiography showing absence of coronary artery calcium cannot reliably exclude coronary artery disease.
AB - Objectives: There is conflicting evidence about the comparative diagnostic accuracy of the Agatston score versus computed tomography angiography (CTA) in patients with suspected obstructive coronary artery disease (CAD). Purpose: To determine whether CTA is superior to the Agatston score in the diagnosis of CAD. Methods: In total 2452 patients with stable chest pain and a clinical indication for invasive coronary angiography (ICA) for suspected CAD were included by the Collaborative Meta-analysis of Cardiac CT (COME-CCT) Consortium. An Agatston score of > 400 was considered positive, and obstructive CAD defined as at least 50% coronary diameter stenosis on ICA was used as the reference standard. Results: Obstructive CAD was diagnosed in 44.9% of patients (1100/2452). The median Agatston score was 74. Diagnostic accuracy of CTA for the detection of obstructive CAD (81.1%, 95% confidence interval [CI]: 77.5 to 84.1%) was significantly higher than that of the Agatston score (68.8%, 95% CI: 64.2 to 73.1%, p < 0.001). Among patients with an Agatston score of zero, 17% (101/600) had obstructive CAD. Diagnostic accuracy of CTA was not significantly different in patients with low to intermediate (1 to < 100, 100–400) versus moderate to high Agatston scores (401–1000, > 1000). Conclusions: Results in our international cohort show CTA to have significantly higher diagnostic accuracy than the Agatston score in patients with stable chest pain, suspected CAD, and a clinical indication for ICA. Diagnostic performance of CTA is not affected by a higher Agatston score while an Agatston score of zero does not reliably exclude obstructive CAD. Key Points: • CTA showed significantly higher diagnostic accuracy (81.1%, 95% confidence interval [CI]: 77.5 to 84.1%) for diagnosis of coronary artery disease when compared to the Agatston score (68.8%, 95% CI: 64.2 to 73.1%, p < 0.001). • Diagnostic performance of CTA was not affected by increased amount of calcium and was not significantly different in patients with low to intermediate (1 to <100, 100–400) versus moderate to high Agatston scores (401–1000, > 1000). • Seventeen percent of patients with an Agatston score of zero showed obstructive coronary artery disease by invasive angiography showing absence of coronary artery calcium cannot reliably exclude coronary artery disease.
KW - Computed tomography angiography
KW - Coronary angiography
KW - Coronary artery disease
UR - http://www.scopus.com/inward/record.url?scp=85126203497&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126203497&partnerID=8YFLogxK
U2 - 10.1007/s00330-022-08619-4
DO - 10.1007/s00330-022-08619-4
M3 - Article
C2 - 35267094
AN - SCOPUS:85126203497
SN - 0938-7994
VL - 32
SP - 5233
EP - 5245
JO - European Radiology
JF - European Radiology
IS - 8
ER -